MD Anderson Events
Use of Vemerafenib in Metastatic Melanoma
- Review common targeted therapy treatment of metastatic melanoma
- Identify pathology findings that indicate a patient is a candidate for BRAF inhibitors
- Identify patients characteristics that indicate use of BRAF inhibitors
- State toxicities of BRAF inhibitors and associated nursing interventions
- Discuss how BRAF is used in combinations therapies
Date: 3/26/13, 1:30pm to 2:30pm
Time: 3/26/13, 1:30pm to 2:30pm
Location: P10 Conference Room
Format: Training/Employee Development
CME: Contact Hours: 1.0
Speaker: Tina Dett, FNP
Contact: Cindy Murphy - 39297 - cmurphy@mdanderson.org
Related Events
Contact Us
Questions? Need help?
Want to request an appointment?
Call askMDAnderson
1-877-MDA-6789
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- How You Can Help
- Children's Art Project
- Directory
- Contact Us
- Sitemap
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Clinical Trials
- News and Publications
- Newsroom
- Publications
- Education and Research
- Departments, Programs & Labs
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- State of Texas
- State of Texas Home Page
- Statewide Search (TRAIL)
- State Comptroller - Where the Money Goes
- Texas Homeland Security
- The University of Texas System
- Institution Resume
- Legal, Policy and Reports
- Reports to the State
- Legal Statements & Site Policies
- Stay Connected
- #endcancer
- Emergency Alerts
- Emergency Alert Information
© 2014 The University of Texas MD Anderson Cancer Center